What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Antibody
Jörg Reimann focuses on Cytotoxic T cell, CTL*, Molecular biology, Virology and Antigen.
His study looks at the relationship between Cytotoxic T cell and topics such as Immune system, which overlap with Antibody.
His CTL* study integrates concerns from other disciplines, such as Plasmid, HBsAg, Hepatitis B virus, MHC class I and Priming.
His Molecular biology research includes themes of T cell, In vitro, DNA vaccination and CD40.
Jörg Reimann has researched Virology in several fields, including CD8, Immunity and In vivo.
Immunology covers Jörg Reimann research in Antigen.
His most cited work include:
- MHC Class I–Restricted CTL Responses to Exogenous Antigens (261 citations)
- Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. (198 citations)
- Commensal Gut Flora Drives the Expansion of Proinflammatory CD4 T Cells in the Colonic Lamina Propria under Normal and Inflammatory Conditions (171 citations)
What are the main themes of his work throughout his whole career to date?
Jörg Reimann mostly deals with Molecular biology, Cytotoxic T cell, Antigen, Virology and Immunology.
The various areas that Jörg Reimann examines in his Molecular biology study include In vitro, T cell, T-cell receptor, Immunogenicity and Epitope.
His work on Antigen-presenting cell as part of general T cell research is frequently linked to Population, bridging the gap between disciplines.
His Cytotoxic T cell research incorporates themes from Priming and CD8.
His research in Antigen intersects with topics in Antibody, Immune system and Fusion protein.
The Virology study combines topics in areas such as Plasmid, DNA vaccination and Recombinant DNA.
He most often published in these fields:
- Molecular biology (53.27%)
- Cytotoxic T cell (49.25%)
- Antigen (36.68%)
What were the highlights of his more recent work (between 2004-2013)?
- Cytotoxic T cell (49.25%)
- Molecular biology (53.27%)
- Priming (21.61%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cytotoxic T cell, Molecular biology, Priming, Virology and Immunology.
His work carried out in the field of Cytotoxic T cell brings together such families of science as CD8, Immunity and Cell biology.
Jörg Reimann works mostly in the field of Molecular biology, limiting it down to topics relating to Fusion protein and, in certain cases, Immune system.
His Priming research is multidisciplinary, relying on both T cell and DNA vaccination.
His research integrates issues of Epitope, Antibody and Immunodominant Epitopes in his study of Virology.
His studies deal with areas such as CD80 and CD40 as well as Immunology.
Between 2004 and 2013, his most popular works were:
- Commensal Gut Flora Drives the Expansion of Proinflammatory CD4 T Cells in the Colonic Lamina Propria under Normal and Inflammatory Conditions (171 citations)
- Evidence for a Functional Second Thymus in Mice (126 citations)
- Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies. (82 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in T cell, Immunology, Cytotoxic T cell, Priming and Molecular biology.
His T cell study incorporates themes from Endocrinology, T lymphocyte, Lymphopoiesis, Cell biology and Transplantation.
He combines subjects such as CD8, Immune system and Virology with his study of Cytotoxic T cell.
The concepts of his Priming study are interwoven with issues in Epitope, Stimulation, Microbiology and Escherichia coli.
His study explores the link between Epitope and topics such as Recombinant DNA that cross with problems in Antigen.
The various areas that Jörg Reimann examines in his Molecular biology study include Cell, Natural killer T cell, Dendritic cell, Hepatitis and Interleukin 22.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
